**Question:** Oxytocin is preferred over ergometrine in:

**Core Concept:**
Oxytocin and ergometrine are uterotonic agents used to induce or augment uterine contractions during labor and delivery. Their primary action is on the uterus, leading to increased contractility. However, they differ in their side effects and mechanism of action.

**Why the Correct Answer is Right:**
Oxytocin is a peptide hormone produced in the hypothalamus and released into the hypophyseal portal system. It acts on oxytocin receptors in the myometrium, leading to increased sensitivity to calcium ions, which results in stronger uterine contractions and better cervical ripening. Oxytocin has fewer side effects compared to ergometrine. In particular, oxytocin does not cause vasoconstriction or systemic effects like flushing, sweating, and increased heart rate, which are associated with ergometrine.

**Why Each Wrong Option is Incorrect:**

A. Oxytocin is not as potent as ergometrine: While both agents can increase uterine contractility, oxytocin is typically administered in higher doses to achieve the same effect as ergometrine. This makes ergometrine more potent.

B. Oxytocin is contraindicated due to side effects: Although oxytocin does have side effects, such as headache and nausea, these are generally milder compared to ergometrine. The primary reason for preferring oxytocin over ergometrine is the reduced systemic effects and vasoconstriction.

C. Ergometrine is contraindicated due to side effects: Ergometrine does have significant side effects like flushing, sweating, increased heart rate, and vasoconstriction. These side effects make ergometrine less desirable compared to oxytocin.

D. Oxytocin is contraindicated due to inadequate uterine contractility: Oxytocin is a potent uterotonic agent, and the primary reason for preferring oxytocin over ergometrine is the reduced systemic effects and vasoconstriction.

**Clinical Pearl:**
Oxytocin and ergometrine are both uterotonic agents used for labor induction and augmentation. However, oxytocin's reduced systemic effects and vasoconstriction make it a safer choice in certain clinical scenarios. Oxytocin is typically preferred in cases where systemic effects of ergometrine, such as flushing, sweating, and increased heart rate, are undesirable. Additionally, oxytocin is generally administered in higher doses to achieve the same effect as ergometrine due to its lower potency.